# Amyloidogenesis of the amylin analogue pramlintide.

> PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-27665170-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27665170-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-27665170-pramlintide-v1.json
- Content SHA-256: `744a142581f7f6e3782bde01518576233032928373822d63793ea41d8ad4136a`

## Claims and source pins

### Headline

Amyloidogenesis of the amylin analogue pramlintide. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

### Summary

PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

### Paragraph 1

PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`](#source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52))

## Sources

<a id="source-pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52"></a>
- **Amyloidogenesis of the amylin analogue pramlintide. · retained source version 1:2019-12-10:current:58e631e24d529c3177ec1325eeae8b36f77a2f55bbeb2d5ce405bbcd74b93ef9** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27665170/) (`pubmed-observation-pmid-27665170-2019-12-10-58e631e24d52`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Amyloidogenesis of the amylin analogue pramlintide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-27665170-pramlintide-v1.json SHA-256: 744a142581f7f6e3782bde01518576233032928373822d63793ea41d8ad4136a.